Articles
| Open Access |
DOI:
https://doi.org/10.37547/ijmscr/Volume03Issue04-02
ASSESSMENT OF THE INFLUENCE OF COMPLEX TREATMENTS ON KIDNEY FUNCTIONAL RESERVE IN PATIENTS WITH LIVER CIRRHOSIS DEVELOPED DUE TO HEPATITIS V AND C.
Abdulazizkhojiev B.R. , Andijan State Medical Institute, Uzbekistan Jo'raeva M.A. , Andijan State Medical Institute, Uzbekistan Ravzatov J.B. , Andijan State Medical Institute, UzbekistanAbstract
Cirrhosis of the liver is manifested by necrosis of hepatocytes, disruption of its normal architecture due to diffuse growth of connective tissue and the formation of regeneration nodules, as well as developing fibrosis. The article presents a modern approach to the treatment of hepatorenal syndrome, one of the severe complications of the disease. The effect of eplerenone, L-ornithine L-aspartate and glutathione drugs on the functional reserve of kidneys was evaluated on the basis of complex treatment.
Keywords
Hepatitis B, hepatitis C, liver cirrhosis, hepatorenal syndrome
References
Bogomolov P.O., Matsievich M.V., Bueverov A.O., Kokina K.Yu., Voronkova N.V., Beznosenko V.D. Cirrhosis cake in Moskovskoy oblast: tsifry and facty // Almanakh klinicheskoy meditsiny. 2018. No. 1. 59-67-s.
Gadaev A.G., Turakulov R.I., Pirmatova N.V., Khujakulova F.I. Evaluation of the functional reserve of the kidneys in patients with chronic heart failure who have had the COVID-19 infection. Nephrology (Saint Petersburg). 2022;26(3):59-65. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-3-59-65.
Ivanov D.D., Gojenko A.I., Savitskaya L.N. Individualization of renoprotection and dependence on raschetnoy skorosti kloboch kovoy filtratsii and funktsionalnogo pochechnogo reserve. Nephrology 2019; 23 (1): 9–14. DOI:10.24884/1561-6274-2019-23-1-9-14.
Osipenko M.F., Voloshina N.B., Shayde N.L. Pathology of the liver with cirrhosis of the liver // Effektivnaya pharmacoterapiya. 2020. T. 16. No. 1. S. 58–61., DOI 10.33978/2307-3586-2020-16-1-58-61.
Amin AA, Alabsawy EI, Jalan R, Davenport A: Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol. 2019, 39:17-30.10.1016/j.semnephrol.2018.10.002.
Basnayake SK, Easterbrook PJ. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. J Viral Hepat. 2016;23(7): 545–59. doi: 10.1111/jvh.12519. 2. GBD 2013.
Fida S, Khurshid SMS, Mansoor H. Frequency of Hepatorenal Syndrome Among Patients With Cirrhosis and Outcome After Treatment. Cureus. 2020 Aug 25;12(8):e10016. doi: 10.7759/cureus.10016. PMID: 32983712; PMCID: PMC7515548.
Ginis P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361(13):1279–90.
Habas E, Ibrahim AR, Moursi MO, Shraim BA, Elgamal ME, Elzouki AN. Update on hepatorenal syndrome: Definition, Pathogenesis, and management. Arab J Gastroenterol. 2022 May;23(2):125-133. doi: 10.1016/j.ajg.2022.01.005. Epub 2022 Apr 23. PMID: 35473682.
Piano S., Romano A., Di Pascoli M., Angeli P. Why and how to measure renal function in patients with liver disease // Liver Int. 2017. Vol. 37. Suppl. 1. P. 116–122.
Planas R, Montoliu S, Ballesty B, Rivera M, Miquel M, Masnou H, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol 2006;4(11):1385–1394.e1.